CTS CORPORATION financials

  1. Home
  2. Financials
  3. CTS
CTS CIK 0000026058

Source: EDGAR filings · Built 2026-06-02T02:46:08Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 86.37M 79.60M 74.07M 106.86M 70.50M 61.92M
EBITDA 117.18M 102.11M 103.76M 122.76M 103.41M 71.80M
Working Capital 143.02M 143.71M 222.31M 213.23M 175.02M 128.30M
Net Debt -57.00M -68.50M -134.52M -131.22M -116.72M -65.32M
Gross Margin 38.43% 36.44% 34.67% 35.87% 35.99% 32.79%
Operating Margin 15.27% 13.83% 13.64% 15.85% 14.91% 10.64%
Net Margin 12.07% 10.78% 11.00% 10.15% -8.16% 8.18%
Return on Equity (ROE) 11.84% 10.50% 11.49% 11.77% -9.03% 8.19%
Return on Assets (ROA) 8.55% 7.25% 8.17% 7.96% -6.30% 5.54%
Current Ratio 2.30× 2.46× 3.29× 2.89× 2.53× 2.22×
Debt-to-Equity 0.05× 0.05× 0.06× 0.05× 0.05× 0.06×
Effective Tax Rate 22.03% 19.11% 19.45% 26.21% 31.23% 23.73%
Cash Conversion Ratio 1.56× 1.77× 1.47× 2.03× -2.06× 2.21×
Accruals Ratio -0.05× -0.06× -0.04× -0.08× -0.19× -0.07×
CapEx Coverage 6.49× 5.27× 6.03× 8.46× 5.51× 5.17×
Free Cash Flow Per Share $2.90 $2.59 $2.35 $3.31 $2.18 $1.90

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 19.58× 29.13× 22.78× 21.31× — 32.39×
P/FCF 14.79× 20.35× 18.65× 11.89× 16.84× 18.06×
FCF Yield 6.76% 4.91% 5.36% 8.41% 5.94% 5.54%
EV / EBITDA 10.03× 14.84× 11.70× 9.10× 10.30× 14.52×
P/S 2.28× 3.08× 2.45× 2.13× 2.30× 2.61×
P/B 2.23× 3.00× 2.56× 2.47× 2.55× 2.62×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 541.32M 514.76M 550.42M 586.87M 512.92M 424.07M
Cost of Goods and Services Sold 333.29M 327.20M 359.56M 376.33M 328.31M 285.00M
Gross Profit 208.03M 187.56M 190.86M 210.54M 184.62M 139.06M
Research and Development Expense 25.27M 23.39M 24.92M 24.10M 23.86M 24.32M
Selling, General and Administrative Expense 98.72M 88.28M 83.82M 91.52M 82.60M 67.79M
Operating Income (Loss) 82.64M 71.19M 75.05M 93.01M 76.48M 45.13M
Income Tax Expense (Benefit) 18.45M 13.11M 14.62M 21.16M -19.01M 10.79M
Net Income (Loss) Attributable to Parent 65.32M 55.47M 60.53M 59.58M -41.87M 34.69M
Earnings Per Share, Basic $2.21 $1.82 $1.93 $1.86 $-1.30 $1.07
Weighted Average Number of Shares Outstanding, Basic 29.51M 30.41M 31.36M 31.97M 32.33M 32.32M
Earnings Per Share, Diluted $2.19 $1.81 $1.92 $1.85 $-1.30 $1.06
Weighted Average Number of Shares Outstanding, Diluted 29.81M 30.72M 31.58M 32.24M 32.33M 32.58M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 82.30M 94.33M 163.88M 156.91M 141.47M 91.77M
Assets, Current 252.71M 242.17M 319.35M 325.76M 289.09M 233.23M
Assets 764.31M 765.43M 741.17M 748.49M 664.46M 626.05M
Liabilities, Current 109.69M 98.46M 97.04M 112.53M 114.07M 104.93M
Liabilities 212.53M 237.22M 214.34M 242.26M 200.88M 202.37M
Stockholders' Equity Attributable to Parent 551.79M 528.21M 526.82M 506.22M 463.58M 423.68M
Common Stock, Shares, Outstanding 28.76M 30.03M 30.82M 31.68M 32.18M 32.28M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 102.11M 98.24M 88.81M 121.20M 86.14M 76.78M
Net Cash Provided by (Used in) Investing Activities -18.51M -140.56M -18.10M -111.19M -15.90M -23.17M
Payments for Repurchase of Common Stock 56.18M 42.60M 40.93M 21.45M 8.79M 8.08M
Net Cash Provided by (Used in) Financing Activities -98.44M -26.89M -65.40M 4.34M -20.71M -61.33M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CTS CIK 0000026058), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FDMT

4D Molecular Therapeutics, Inc.

ORLY

O Reilly Automotive Inc

ABEO

ABEONA THERAPEUTICS INC.